Brain+ A/S
Develops digital therapeutics for the detection and treatment of cognitive decline.
BRAINP | ST
Overview
Corporate Details
- ISIN(s):
- DK0061670205
- LEI:
- 9845007708709CEGD845
- Country:
- Denmark
- Address:
- Købmagergade 53, 3., 1150 København K
- Website:
- https://www.brain-plus.com/
- Industry:
- Computer programming activities
Description
Brain+ A/S is a health technology company that develops digital therapeutics for the detection and treatment of cognitive decline, primarily in individuals with dementia and Alzheimer's disease. The company focuses on digitalizing Cognitive Stimulation Therapy (CST), a clinically-proven, non-pharmacological treatment recommended by global health organizations. Its primary product is the Ayla platform, a digital CST assistant designed for healthcare providers. Ayla offers standardized, adaptable, and validated therapeutic activities to help delay cognitive decline, improve communication skills, and enhance the quality of life for patients, while also increasing efficiency for care providers by reducing preparation time.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Brain+ A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Brain+ A/S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Brain+ A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
